The U.S. pharmaceutical sector finds itself at a critical juncture with the rollout of President Donald J. Trump’s SAPIR (Strategic Active Pharmaceutical Ingredients Reserve) Initiative, a groundbreaking policy introduced via an Executive Order on August 13 of this year. This ambitious plan seeks
The viral vector and plasmid DNA manufacturing market stands at the threshold of a transformative era, propelled by an escalating demand for gene therapies, vaccines, and personalized medical solutions that are reshaping the landscape of healthcare. These technologies, essential for delivering
In an era where industries are increasingly pressured to balance growth with environmental responsibility, Chevron Phillips Chemical (CPChem) has taken a significant step forward with a major expansion of its low-viscosity polyalphaolefins (LV PAO) production facility in Beringen, Belgium. This
In a significant move to strengthen the pharmaceutical landscape in the United States, AbbVie, a prominent player in the industry, has unveiled a substantial $195 million investment to enhance its active pharmaceutical ingredient (API) manufacturing capabilities at its North Chicago, Illinois
In a world increasingly focused on sustainability, the unexpected downturn in U.S. paper recycling rates during 2024 has raised eyebrows among environmentalists and industry experts alike, prompting a closer examination of the factors at play. Despite decades of progress in building robust
In a remarkable leap toward sustainable agriculture, China has pioneered an innovative approach through green technology to address the intertwined challenges of feeding an enormous population and preserving the environment. With nearly one-fifth of the global population but only one-tenth of the
